Niki BioSolutions, Inc. (NIKI) Accumulated Expenses (2017 - 2025)

Niki BioSolutions (NIKI) has 9 years of Accumulated Expenses data on file, last reported at $19248.0 in Q4 2025.

• Quarterly Accumulated Expenses changed N/A year-over-year to $19248.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $19248.0 (changed N/A YoY) and the FY2025 annual result came in at $5884.0, down 52.1% from the prior year.
• Accumulated Expenses rose to $19248.0 in Q4 2025, from $12154.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $5.1 million in Q4 2022 to a low of $5884.0 in Q2 2025.
• A 5-year average of $585826.7 and a median of $34591.5 in 2021 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses surged 3648.71% — and 2023, when it plunged 91.12%.
• Tracing NIKI's Accumulated Expenses over 5 years: stood at $135646.0 in 2021, then surged by 3648.71% to $5.1 million in 2022, then sank by 91.12% to $451660.0 in 2023, then slumped by 97.28% to $12285.0 in 2024, then soared by 56.68% to $19248.0 in 2025.
• The last three Accumulated Expenses figures came in at $19248.0 (Q4 2025), $12154.0 (Q3 2025), and $5884.0 (Q2 2025), per Business Quant data.